We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+10.33%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$70.7B
AUM Growth
+$2.25B
Cap. Flow
-$3.76B
Cap. Flow %
-5.32%
Top 10 Hldgs %
10.84%
Holding
2,524
New
171
Increased
580
Reduced
1,478
Closed
87

Top Sells

Rank Stock Value
1
ALL icon
Allstate
ALL
+$693M
2
INTC icon
Intel
INTC
+$664M
3
T icon
AT&T
T
+$547M
4
PARA
Paramount Global Class B
PARA
+$295M
5
DIS icon
Walt Disney
DIS
+$173M

Sector Composition

Rank Sector Weight
1 Technology 17.73%
2 Healthcare 15.12%
3 Financials 14.74%
4 Industrials 12.02%
5 Consumer Discretionary 9.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXTR icon
2226
Extreme Networks
EXTR
$3.86B
$20K ﹤0.01%
2,289
-1,085
-32% -$9.45K
GOCO
2227
DELISTED
GoHealth
GOCO
$20K ﹤0.01%
+114
New +$23K
GRVY
2228
GRAVITY
GRVY
$427M
$20K ﹤0.01%
+176
New +$27.3K
LRN icon
2229
Stride
LRN
$3.69B
$20K ﹤0.01%
678
-1,343
-66% -$34.9K
MSEX icon
2230
Middlesex Water
MSEX
$1.05B
$20K ﹤0.01%
256
-121
-32% -$9.16K
MTRN icon
2231
Materion
MTRN
$5.01B
$20K ﹤0.01%
300
-142
-32% -$9.85K
NNI icon
2232
Nelnet
NNI
$4.79B
$20K ﹤0.01%
278
-132
-32% -$9.56K
OCFC icon
2233
OceanFirst Financial
OCFC
$1.7B
$20K ﹤0.01%
816
-387
-32% -$8.32K
OXM icon
2234
Oxford Industries
OXM
$577M
$20K ﹤0.01%
228
-108
-32% -$8.3K
GTHX
2235
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$20K ﹤0.01%
842
-258
-23% -$6K
CSTM icon
2236
Constellium
CSTM
$3.96B
$19K ﹤0.01%
1,280
-607
-32% -$8.72K
EIG icon
2237
Employers Holdings
EIG
$908M
$19K ﹤0.01%
436
-206
-32% -$7.18K
FCF icon
2238
First Commonwealth Financial
FCF
$2.12B
$19K ﹤0.01%
1,303
-617
-32% -$8.21K
MGY icon
2239
Magnolia Oil & Gas
MGY
$5.83B
$19K ﹤0.01%
1,633
-774
-32% -$8.06K
MRTN icon
2240
Marten Transport
MRTN
$1.33B
$19K ﹤0.01%
1,120
-531
-32% -$8.98K
OCUL icon
2241
Ocular Therapeutix
OCUL
$1.86B
$19K ﹤0.01%
1,184
-562
-32% -$10.8K
PFS icon
2242
Provident Financial Services
PFS
$3.11B
$19K ﹤0.01%
840
-398
-32% -$8.14K
PJT icon
2243
PJT Partners
PJT
$4.37B
$19K ﹤0.01%
279
-133
-32% -$9.63K
PLOW icon
2244
Douglas Dynamics
PLOW
$1.07B
$19K ﹤0.01%
413
-196
-32% -$9.03K
PLUS icon
2245
ePlus
PLUS
$2.33B
$19K ﹤0.01%
374
-178
-32% -$8.44K
PRA
2246
DELISTED
ProAssurance
PRA
$19K ﹤0.01%
692
-328
-32% -$7.59K
RLAY icon
2247
Relay Therapeutics
RLAY
$4.02B
$19K ﹤0.01%
543
-257
-32% -$11.2K
TTGT icon
2248
TechTarget
TTGT
$246M
$19K ﹤0.01%
274
-130
-32% -$10.1K
URGN icon
2249
UroGen Pharma
URGN
$2B
$19K ﹤0.01%
959
-163
-15% -$3.46K
LGTY
2250
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$19K ﹤0.01%
919
-436
-32% -$8.73K

Similar funds

Macquarie Group's Q1 2021 Portfolio in Review

As of Q1 2021, Macquarie Group held 2,524 positions worth $70.7B, up 3.3% from $68.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Macquarie Group withdrew a net $3.76B in Q1 2021, closing 87 positions and reducing 1,478 holdings. Its most notable exit was iShares Core S&P Total US Stock Market ETF, an estimated $140M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Macquarie Group opened a new position in Sunrun worth $77.7M.

  • Macquarie Group's largest Q1 2021 buy was Sunrun: 1,285,424 shares worth $77.7M.
  • Macquarie Group added most to MetLife in Q1 2021, an estimated $627M increase.
  • Macquarie Group's biggest Q1 2021 reduction was Allstate, cutting an estimated $693M.
  • Macquarie Group fully exited iShares Core S&P Total US Stock Market ETF in Q1 2021, selling an estimated $140M.
  • Macquarie Group's ten largest holdings make up 11% of its $70.7B portfolio in Q1 2021.
  • Macquarie Group opened 171 new positions and closed 87 in Q1 2021.
  • Macquarie Group's portfolio value rose 3.3% quarter-over-quarter to $70.7B.

Based on Macquarie Group's 13F filing for Q1 2021, filed 14 May 2021.